Suppr超能文献

用于预靶向生物正交正电子发射断层扫描成像的高活性四嗪的直接铜介导芳基氟标记

Direct Cu-mediated aromatic F-labeling of highly reactive tetrazines for pretargeted bioorthogonal PET imaging.

作者信息

García-Vázquez Rocío, Battisti Umberto M, Jørgensen Jesper T, Shalgunov Vladimir, Hvass Lars, Stares Daniel L, Petersen Ida N, Crestey François, Löffler Andreas, Svatunek Dennis, Kristensen Jesper L, Mikula Hannes, Kjaer Andreas, Herth Matthias M

机构信息

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen Jagtvej 160 2100 Copenhagen Denmark

Department of Clinical Physiology, Nuclear Medicine & PET Rigshospitalet, Blegdamsvej 9 2100 Copenhagen Denmark.

出版信息

Chem Sci. 2021 Jul 28;12(35):11668-11675. doi: 10.1039/d1sc02789a. eCollection 2021 Sep 15.

Abstract

Pretargeted imaging can be used to visualize and quantify slow-accumulating targeting vectors with short-lived radionuclides such as fluorine-18 - the most popular clinically applied Positron Emission Tomography (PET) radionuclide. Pretargeting results in higher target-to-background ratios compared to conventional imaging approaches using long-lived radionuclides. Currently, the tetrazine ligation is the most popular bioorthogonal reaction for pretargeted imaging, but a direct F-labeling strategy for highly reactive tetrazines, which would be highly beneficial if not essential for clinical translation, has thus far not been reported. In this work, a simple, scalable and reliable direct F-labeling procedure has been developed. We initially studied the applicability of different leaving groups and labeling methods to develop this procedure. The copper-mediated F-labeling exploiting stannane precursors showed the most promising results. This approach was then successfully applied to a set of tetrazines, including highly reactive H-tetrazines, suitable for pretargeted PET imaging. The labeling succeeded in radiochemical yields (RCYs) of up to approx. 25%. The new procedure was then applied to develop a pretargeting tetrazine-based imaging agent. The tracer was synthesized in a satisfactory RCY of 10%, with a molar activity of 134 ± 22 GBq μmol and a radiochemical purity of >99%. Further evaluation showed that the tracer displayed favorable characteristics (target-to-background ratios and clearance) that may qualify it for future clinical translation.

摘要

预靶向成像可用于可视化和定量具有短寿命放射性核素(如氟 - 18,临床上最常用的正电子发射断层扫描(PET)放射性核素)的缓慢积累的靶向载体。与使用长寿命放射性核素的传统成像方法相比,预靶向可实现更高的靶本底比。目前,四嗪连接是预靶向成像中最常用的生物正交反应,但对于高活性四嗪的直接F标记策略,尽管对临床转化可能并非必不可少,但如果可行将非常有益,而迄今为止尚未见报道。在这项工作中,开发了一种简单、可扩展且可靠的直接F标记程序。我们最初研究了不同离去基团和标记方法在开发该程序中的适用性。利用锡烷前体的铜介导F标记显示出最有前景的结果。然后该方法成功应用于一组四嗪,包括适用于预靶向PET成像的高活性H - 四嗪。标记的放射化学产率(RCY)高达约25%。然后将新程序应用于开发一种基于四嗪的预靶向成像剂。该示踪剂的合成放射化学产率令人满意,为10%,摩尔活度为134±22 GBq/μmol,放射化学纯度>99%。进一步评估表明,该示踪剂具有良好的特性(靶本底比和清除率),可能使其有资格用于未来的临床转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc04/8442695/e6136f277397/d1sc02789a-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验